NCT07222852RecruitingPhase 3
Cardiovascular Protection After Preeclampsia With Enalapril
Source: ClinicalTrials.gov · Last updated 6 Aug 2026
Brief summary (registry, in English)
The purpose of this study is to learn if postpartum women are willing to be randomized to different blood pressure medicines after delivery and how that affects blood pressure in women with hypertensive disorders of pregnancy.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 2 Oct 2025
- Start date
- Jan 2026
- Primary completion date
- Oct 2027
- Lead sponsor
- Women and Infants Hospital of Rhode Island
- Diseases
- High blood pressure
- NCT number
- NCT07222852
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 60
- From Jan 2026 to the primary completion date, Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Maternal cardiac disease
- Individuals with pre-pregnancy hypertension or diabetes
- Allergy or contraindication to enalapril
Who the study is looking for
- Postpartum individuals
- ≥18 years old
- Hypertensive disorder of pregnancy
- Enrolled in Women and Infants Hospital Hypertension Equity remote monitoring program.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Women and Infants Hospital Coordinator of this site? Confirm its status | Providence | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.